# Careviso

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/careviso

- Industry: Healthcare
- Headquarters: Falls Church, US
- Website: www.careviso.com
- Total disclosed funding: $13M
- Latest round: Series B (Jul 15, 2022)
- Investors on record: 3

## About

Based in Virginia, US, and founded in 2017 by Andrew Mignatti (CEO), and Perry Dimas, Careviso Inc. operates as a healthcare company that assists patients in obtaining the diagnostic tests they require by easing the administrative burden on physicians and laboratories. In September 2022, Careviso Inc. raised USD 17 million in Series B funding led by Ballast Point Ventures, returning investors Lytical Ventures and Mercury also participated in the round.

Careviso Inc. provides products known as seeQer which provides answers to patients' frequently asked questions and seerEZ which assists patients in gaining access to diagnostic testing. The company removes barriers and improves patient access to diagnostic testing through a long-term solution that directs involving payors, physicians, laboratories, and the patient, allowing healthcare organizations to simplify administrative tasks for patients, doctors, and insurance providers.

The company plans to use the September 2022 funding to expand its existing technology platform into the diagnostic space.

## Funding rounds

- Series B, Jul 15, 2022, $13M — Ballast Point Ventures, Mercury, Lytical Ventures
- Series A, Mar 16, 2021 — Mercury, Lytical Ventures

## Investors

- Mercury (https://capitalatlas.ai/funds/mercury) — Series A, Series B
- Lytical Ventures (https://capitalatlas.ai/funds/lytical-ventures) — Series A, Series B
- Ballast Point Ventures (https://capitalatlas.ai/funds/ballast-point-ventures) — Series B